Compounds > glimepiride

glimepiride and insulin, isophane

glimepiride has been researched along with insulin, isophane in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's8 (88.89)29.6817
2010's1 (11.11)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fritsche, A; Häring, HU; Schweitzer, MA1
Gupta, G; Hassan, S; Hassan, Y1
Mikhail, N; Wali, S1
Aschner, P; Calvo, C; Eliaschewitz, FG; Jimenez, J; Ramirez, LA; Ruiz, M; Valbuena, H; Villena, J1
Chung, KD; Kim, KW; Pan, CY; Sinnassamy, P1
Kann, PH; Medding, J; Moeller, J; Mokan, M; Mrevlje, F; Regulski, M; Szocs, A; Wascher, T; Zackova, V1
Kaneto, H; Kasami, R; Kawashima, S; Kuroda, A; Matsuhisa, M; Matsuoka, TA; Sakamoto, K; Shiraiwa, T; Yamamoto, K; Yamasaki, Y; Yasuda, T1
Bolli, GB; Candelas, C; Dain, MP; Deerochanawong, C; Home, PD; Landgraf, W; Mathieu, C; Pilorget, V; Riddle, MC1

Trials

5 trial(s) available for glimepiride and insulin, isophane

ArticleYear
Glimepiride combined with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes. A randomized, controlled trial.
    Annals of internal medicine, 2003, Jun-17, Volume: 138, Issue:12

    Topics: Aged; Blood Glucose; Diabetes Mellitus, Type 2; Drug Administration Schedule; Female; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulin Glargine; Insulin, Isophane; Insulin, Long-Acting; Male; Middle Aged; Risk Factors; Sulfonylurea Compounds; Weight Gain

2003
Therapy in type 2 diabetes: insulin glargine vs. NPH insulin both in combination with glimepiride.
    Archives of medical research, 2006, Volume: 37, Issue:4

    Topics: Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Humans; Hypoglycemia; Insulin; Insulin Glargine; Insulin, Isophane; Insulin, Long-Acting; Male; Middle Aged; Sulfonylurea Compounds

2006
Insulin glargine versus NPH insulin therapy in Asian Type 2 diabetes patients.
    Diabetes research and clinical practice, 2007, Volume: 76, Issue:1

    Topics: Asian People; Blood Glucose; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulin Glargine; Insulin, Isophane; Insulin, Long-Acting; Male; Middle Aged; Sulfonylurea Compounds; Treatment Outcome

2007
Starting insulin therapy in type 2 diabetes: twice-daily biphasic insulin Aspart 30 plus metformin versus once-daily insulin glargine plus glimepiride.
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2006, Volume: 114, Issue:9

    Topics: Aged; Biphasic Insulins; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Insulin Aspart; Insulin Glargine; Insulin, Isophane; Insulin, Long-Acting; Male; Metformin; Middle Aged; Sulfonylurea Compounds; Treatment Outcome

2006
Modulation of insulin dose titration using a hypoglycaemia-sensitive algorithm: insulin glargine versus neutral protamine Hagedorn insulin in insulin-naïve people with type 2 diabetes.
    Diabetes, obesity & metabolism, 2015, Volume: 17, Issue:1

    Topics: Aged; Asia; Blood Glucose Self-Monitoring; Circadian Rhythm; Diabetes Mellitus, Type 2; Drug Dosage Calculations; Drug Resistance; Drug Therapy, Combination; Europe; Female; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Insulin Glargine; Insulin, Isophane; Insulin, Long-Acting; Male; Metformin; Middle Aged; Middle East; South Africa; Sulfonylurea Compounds

2015

Other Studies

4 other study(ies) available for glimepiride and insulin, isophane

ArticleYear
Summaries for patients. A comparison of three insulin regimens (morning glargine, bedtime glargine, or bedtime neutral protamine Hagedorn) in addition to a pill for treating type 2 diabetes.
    Annals of internal medicine, 2003, Jun-17, Volume: 138, Issue:12

    Topics: Aged; Diabetes Mellitus, Type 2; Drug Administration Schedule; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Glargine; Insulin, Isophane; Insulin, Long-Acting; Male; Middle Aged; Sulfonylurea Compounds

2003
Insulin combination therapy in type 2 diabetes mellitus.
    Annals of internal medicine, 2004, Apr-20, Volume: 140, Issue:8

    Topics: Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Insulin; Insulin Glargine; Insulin, Isophane; Insulin, Long-Acting; Sulfonylurea Compounds

2004
Insulin combination therapy in type 2 diabetes mellitus.
    Annals of internal medicine, 2004, Apr-20, Volume: 140, Issue:8

    Topics: Diabetes Mellitus, Type 2; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Insulin; Insulin Glargine; Insulin, Isophane; Insulin, Long-Acting; Research Design; Sulfonylurea Compounds

2004
Acute progression of severe insulin edema accompanied by pericardial and pleural effusion in a patient with type 2 diabetes.
    Diabetes research and clinical practice, 2008, Volume: 81, Issue:2

    Topics: Administration, Oral; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Disease Progression; Edema; Humans; Hypoglycemic Agents; Inositol; Insulin, Isophane; Male; Middle Aged; Pericardial Effusion; Pleural Effusion; Sulfonylurea Compounds

2008